The Key To Big Pharma Deals: How Korea's ABL Reached $1bn Sanofi Agreement

Science, Data Form Backbone

 
• By Jung Won Shin
Sang Hoon Lee, ABL Bio CEO
ABL Bio CEO Sang Hoon Lee Talks Around Ambitions To Set New Role Model For Korean Biotechs • Source: ABL Bio

More from South Korea

More from Focus On Asia